Chemical Structure : Satraplatin
CAS No.: 129580-63-8
货号: PC-45364Not For Human Use, Lab Use Only.
Satraplatin (BMS-182751, BMY-45594, JM-216) is a platinum-based antineoplastic agent that binds to guanine residues in DNA, inhibits DNA replication and transcription, leads to subsequent apoptosis.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥2280 | In stock | |
10 mg | ¥3780 | In stock | |
25 mg | ¥5980 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Satraplatin (BMS-182751, BMY-45594, JM-216) is a platinum-based antineoplastic agent that binds to guanine residues in DNA, inhibits DNA replication and transcription, leads to subsequent apoptosis.
Satraplatin shows similar cytotoxicity and pattern of cytotoxicity to cisplatin against human ovarian carcinoma cell lines (IC50=1.7 uM).
Satraplatin shows antitumor selectivity far superior to cisplatin, carboplatin, or tetraplatin in vivo; orally active.
分子量 | 500.2816 | |
分子式 | C10H22Cl2N2O4Pt+2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 33 mg/mL |
|
Chemical Name/SMILES |
Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)- (9CI) |
1. Kelland LR, et al. Cancer Res. 1993 Jun 1;53(11):2581-6.
2. Mellish KJ, et al. Br J Cancer. 1993 Aug;68(2):240-50.
3. Ricart AD, et al. Clin Cancer Res. 2009 Jun 1;15(11):3866-71.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright